ArticleRegenerative biomaterials2026
Ultrasound-activated UiO-66 enables ROS-mediated antibacterial therapy and accelerates diabetic wound healing.
Article in Regenerative biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ROS-Balancing MXene/MoSeSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- Adaptive hydrogel platforms for infected bone defect repair: microenvironmental responsiveness, osteoimmunomodulation, and regenerative remodeling.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of noninvasive and dual-functional therapeutic strategies is of critical importance for the treatment of infected diabetic wounds, which require both effective bacterial eradication and enhanced tissue regeneration. Conventional approaches are frequently constrained by single-function modalities or adverse side effects, emphasizing the demand for safer and more versatile alternatives. In this study, we demonstrate for the first time that pristine UiO-66, a metal-organic framework without surface modification, can serve as a novel nanoplatform for sonodynamic therapy (SDT), simultaneously achieving antibacterial and pro-regenerative effects. Comprehensive structural and photochemical analyses reveal that UiO-66 efficiently generates reactive oxygen species (ROS) under ultrasound irradiation, which endow it with broad-spectrum antibacterial capacity. These effects are validated by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.